Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20038030HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20048589HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20026706HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20048288HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20033039HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20021233HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20032030HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44018639HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44021744HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44029331HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TCGA Plot Options
Drug Information
GeneCHRM3
DrugBank IDDB00363
Drug NameClozapine
Target IDBE0000045
UniProt IDP20309
Regulation Typeantagonist
PubMed IDs17848919; 33647377
CitationsNasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11.@@Foster DJ, Bryant ZK, Conn PJ: Targeting muscarinic receptors to treat schizophrenia. Behav Brain Res. 2021 May 7;405:113201. doi: 10.1016/j.bbr.2021.113201. Epub 2021 Feb 26.
GroupsApproved
Direct ClassificationDibenzodiazepines
SMILESCN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Pathways
PharmGKBPA449061
ChEMBLCHEMBL42